Otsuka Holdings
4578.T
#726
Rank
HK$275.21 B
Marketcap
HK$521.10
Share price
0.05%
Change (1 day)
38.08%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: HK$8.22 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are HK$14.47 Billion. In 2023 the company made an earning of HK$8.22 Billion a decrease over its 2022 earnings that were of HK$10.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023HK$8.22 B-20.93%
2022HK$10.40 B-12.7%
2021HK$11.91 B-19.92%
2020HK$14.87 B13.9%
2019HK$13.06 B52.07%
2018HK$8.59 B11.22%
2017HK$7.72 B-36.03%
2016HK$12.07 B31.15%
2015HK$9.20 B
2013HK$19.10 B33.52%
2012HK$14.31 B-4.65%
2011HK$15.00 B45.53%
2010HK$10.31 B